Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Depression 4Depressive Disorder, Major 2Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms 1Lymphoma, Follicular 1Lung Neoplasms 1Liver Neoplasms 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Fatigue 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bile Duct Neoplasms 1Asthma 1

Interventions

Escitalopram 2Sugars 1Saline Solution 1Infliximab 1Fatty Acids, Omega-3 1Desvenlafaxine Succinate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Depressive Disorder, Major × Escitalopram × Clear all
NCT00536172 2023-09-21

PROTECT

University of Nebraska

Phase 4 Completed
160 enrolled 15 charts
Head & Neck

Depression, Depressive Disorder, Major, Head and Neck Neoplasms

NCT00621946 2014-02-04

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

University of Texas Southwestern Medical Center

Phase 4 Completed
26 enrolled 13 charts
Lymphoid

Asthma, Depression, Depressive Disorder, Major, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡